Labshake search
Citations for Lonza :
1 - 50 of 986 citations for Recombinant Human Interleukin 7 Receptor Fc His since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Bioengineering 2024Quote: ... and recombinant human insulin 0.5%) (Lonza). Human cervical cancer cell line SiHa from ATCC (ATCC® HTB-35™ ...
-
bioRxiv - Cancer Biology 2022Quote: ... human recombinant insulin (20 μg/mL, Lonza, #BE03-033E20), human recombinant EGF (2 ng/mL ...
-
bioRxiv - Bioengineering 2020Quote: ... Primary (Lifeline: FC-0049) and Human Lung Microvascular Endothelial Cells (Lonza: CC-2527) were grown in T-75 culture flasks in an atmosphere of 5% CO2 at 37°C according to the instructions provide by the manufacturers ...
-
bioRxiv - Bioengineering 2023Quote: Primary human umbilical vein endothelial cells (HUVECs; Lonza; passages 4 to 7) were cultured on dishes in Endothelial Cell Growth Medium-2 (EGM-2 ...
-
bioRxiv - Biophysics 2020Quote: ... hydrocortisone and recombinant human epidermal growth factor (MEGM Bullet Kit CC-4136; Lonza). Cells were maintained in an incubator under standard conditions (36.5 °C ...
-
bioRxiv - Genetics 2021Quote: ... RNPs containing recombinant CRISPR/Cas9 and sgRNA were transfected to human cell lines using a Nucleofector (Lonza). Stable cell lines were generated by selection of hygrogmycin resistance ...
-
bioRxiv - Pharmacology and Toxicology 2020Quote: ... 100 μg/ml streptomycin and 15 ng/ml recombinant human macrophage colony stimulating factor (Lonza, Melbourne, Australia) on 10 mm square dishes (Bio-strategy ...
-
bioRxiv - Cell Biology 2020Quote: ... 20% FCS (Lonza), 2 mM L-Glutamine ...
-
bioRxiv - Genomics 2020Quote: ... 10% FCS (Lonza), 1% antibiotic/antimycotic (Life Technologies ...
-
bioRxiv - Biochemistry 2021Quote: ... 100 μg ml−1 streptomycin and 15 ng ml−1 recombinant human macrophage colony stimulating factor (Lonza, Melbourne, Australia) on 10 mm square dishes (Bio-strategy ...
-
bioRxiv - Neuroscience 2021Quote: ... supplemented with 0.1 μg/ml of interleukin (IL)-34 (IL-34) (Lonza, Basel-Stadt, Switzerland), 0.01 μg/ml of granulocyte-macrophage colony-stimulating factor (GM-CSF ...
-
bioRxiv - Cell Biology 2023Quote: ... supplemented with 0.1 μg/mL of interleukin (IL)-34 (IL-34) (Lonza, Basel-Stadt, Switzerland), 0.01 μg/mL of granulocyte-macrophage colony-stimulating factor (GM-CSF ...
-
bioRxiv - Molecular Biology 2020Quote: ... containing 10% FCS (Lonza),2 mM L-Glutamin ...
-
bioRxiv - Cell Biology 2021Quote: ... supplemented with 10% FCS (Lonza), 1% L-glutamine (Sigma) ...
-
bioRxiv - Cell Biology 2019Quote: ... supplemented with 10% FCS (Lonza), 1% L-glutamine (Sigma) ...
-
bioRxiv - Biochemistry 2023Quote: ... Medium containing 5% FCS (Lonza) was used to expand and grow cells in a Cell Factory (6320 cm2 ...
-
bioRxiv - Immunology 2023Quote: ... supplemented with 10% FCS (Lonza), 2 mM L-glutamine ...
-
bioRxiv - Molecular Biology 2023Quote: ... 10% foetal calf serum (FCS, Lonza) and grown at 37°C ...
-
bioRxiv - Cell Biology 2021Quote: ... supplemented with 10% (v/v) FCS (Lonza), 1% (v/v ...
-
bioRxiv - Immunology 2021Quote: ... supplemented with 10% heat-inactivated FCS (Lonza) and 1% 0.5M EDTA (Sigma-Aldrich) ...
-
bioRxiv - Cell Biology 2022Quote: ... 20 % v/v FCS (Lonza, Basel, Switzerland), 2 mM L-Glutamine ...
-
bioRxiv - Microbiology 2022Quote: ... for 24 h then interleukin-2 (50U/ml) for 4-6 days before nucleofection (as recommended by the manufacturer, Lonza) or infection by HIV-1.
-
bioRxiv - Immunology 2022Quote: ... supplemented with fetal calf serum (FCS, 3%, Lonza) and HEPES (1.8%) ...
-
bioRxiv - Immunology 2022Quote: ... supplemented with fetal calf serum (FCS, 3%, Lonza) and HEPES (1.8% ...
-
bioRxiv - Cancer Biology 2021Quote: ... supplemented with 10% fetal calf serum (FCS, Lonza), 50 units/mL penicillin and 50 μg/mL streptomycin (P/S ...
-
bioRxiv - Developmental Biology 2020Quote: ... supplemented with 10% fetal calf serum (FCS) (Lonza), 2 mM Sodium pyruvate (Gibco) ...
-
bioRxiv - Immunology 2019Quote: ... in 1% FCS and 20mM HEPES in PBS (Lonza). Samples were dissociated with GentleMACS Octo for 30 minutes homogenising/37°C cycle ...
-
Strong paracrine effects of SASP from senescence-induced severe early-onset COPD-derived fibroblastsbioRxiv - Cell Biology 2023Quote: ... with 10% Fetal Calf Serum (FCS) (Lonza, Basel, Switzerland), L-glutamine (Lonza) ...
-
bioRxiv - Neuroscience 2019Quote: COS-7 cells were maintained in DMEM (Lonza) supplemented with 10 % FBS (Sigma) ...
-
bioRxiv - Cancer Biology 2020Quote: ... recombinant Cas9 nuclease (IDT) and the 4D-Nucleofector (Lonza) as previously described (Wagenblast et al. ...
-
bioRxiv - Cell Biology 2020Quote: ... supplemented with 20% fetal calf serum (FCS; Lonza Group, Ltd.). Primary human mammary epithelial cells (HuMECs ...
-
bioRxiv - Cancer Biology 2022Quote: ... and 10% heat-inactivated fetal calf serum (FCS, Lonza, Switzerland) and cultured at 37°C and 5% CO2 ...
-
bioRxiv - Molecular Biology 2020Quote: ... and 5% (V/V) FCS (LO CC-3202/6, Lonza) up to 70-75% confluency ...
-
bioRxiv - Microbiology 2021Quote: ... supplemented with 10% (vol/vol) fetal calf serum (FCS; Lonza). All cell lines were grown at 37 °C in 5% CO2 ...
-
bioRxiv - Immunology 2022Quote: ... Co-cultures were done in IMDM supplemented with 5% HI-HS (Lonza) and gentamycin (86 μg/mL ...
-
bioRxiv - Genomics 2022Quote: Human primary proximal tubular cells (human RPTEC, Lonza; CC-2553) were cultured with renal epithelial cell growth medium kit (Lonza ...
-
bioRxiv - Genomics 2021Quote: ... Human primary proximal tubular cells (human RPTEC, Lonza; CC-2553) were cultured with renal epithelial cell growth medium kit (Lonza ...
-
bioRxiv - Immunology 2021Quote: ... Cells were differentiating for 7 days in DMEM (Lonza) supplemented with 25% of L929 medium ...
-
bioRxiv - Bioengineering 2022Quote: Human (Lonza, HUM4198) and rhesus macaque (Lonza ...
-
bioRxiv - Immunology 2020Quote: ... supplemented with 10% FCS and 2 mM glutamine (Lonza, BE17-605F). For lentivirus production ...
-
bioRxiv - Biophysics 2023Quote: ... with or without 10% fetal calf serum (FCS, Lonza, Basel, Switzerland) in a 37°C incubator with 5% CO2 ...
-
bioRxiv - Immunology 2021Quote: ... Silencing of the zinc receptor Gpr39 was performed by electroporation using Nucleofector electroporation kit (VPI-1001, Lonza) for exECs (Program M-003 ...
-
bioRxiv - Molecular Biology 2024Quote: CRISPR/Cas9 was used to knockout the coxsackie and adenovirus receptor CXADR by nucleofection (Lonza, Basel Switzerland). Well-differentiated human airway epithelia were lifted in TrypLE and electroporated with ribonucleoproteins (RNP) ...
-
bioRxiv - Genomics 2024Quote: Human primary proximal tubular cells (human primary PTC, Lonza; CC-2553) were cultured with renal epithelial cell growth medium kit (Lonza ...
-
bioRxiv - Biochemistry 2020Quote: COS-7 cells were cultured in 50/50 DMEM (Lonza)/Ham’s F10 (Lonza ...
-
bioRxiv - Developmental Biology 2019Quote: ... embryos were embedded in 7% low-melting point agarose (Lonza) and sagittal tissue sections at 100 µm thickness were cut on a VT1000S vibratome (Leica) ...
-
bioRxiv - Cell Biology 2022Quote: ... Primary human melanocytes (Normal Human Epidermal Melanocytes, NHEM) were obtained from Lonza. All cell culture reagents were obtained from GIBCO Life technologies ...
-
bioRxiv - Bioengineering 2021Quote: Human MSCs were isolated from fresh bone marrow from human donors (Lonza, male 23 years ...
-
bioRxiv - Immunology 2021Quote: ... supplemented with 10% Foetal Calf Serum (FCS) (PAA,, AT or Lonza, CH), 100U/mL penicillin (Sigma-Alrdich ...
-
bioRxiv - Molecular Biology 2022Quote: Human primary EC(Lonza) were cultured in complete endothelial basal medium (EBM ...